Brain, Vol. 113, No. 2, 433-445, 1990
© 1990 Oxford University Press
research-article |
ACUTE INFANTILE SPINAL MUSCULAR ATROPHY
MUSCLE APOPTOSIS AS A PROPOSED PATHOGENETIC MECHANISM
SKA1,1Department of Neurology, Medical Academy, Warsaw Poland 2Division of Neuropathology, University of Mainz Mainz, FRG
Correspondence to:
Correspondence to: Dr Anna Fidzia
ska, Department of Neurology, Medical Academy, Banacha I, Warsaw, Poland.
Biopsy as well as autopsy studies of a child who died 8 weeks after birth from the acute infantile form of spinal muscular atrophy revealed classical morphological changes, including degeneration and loss of motoneurons in the spinal cord, loss of large myelinated fibres in anterior roots and neurogenic atrophy in muscle. New ultrastructural findings include massive muscle cell elimination by apoptosis with the formation of membrane-bound muscle cell fragments, apoptotic bodies. In addition, numerous immature muscle fibres were observed. The morphological findings raise the possibility that in a severely growth-retarded muscle, the process of muscle cell apoptosis removes the peripheral target of anterior horn cells resulting in secondary motoneuron death.
Received December 20, 1988. Revised April 25, 1989. Accepted May 12, 1989.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. J. Sumner, C. D. Wee, L. C. Warsing, D. W. Choe, A. S. Ng, C. Lutz, and K. R. Wagner Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice Hum. Mol. Genet., September 1, 2009; 18(17): 3145 - 3152. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Sumner Molecular Mechanisms of Spinal Muscular Atrophy J Child Neurol, August 1, 2007; 22(8): 979 - 989. [Abstract] [PDF] |
||||
![]() |
S. Rudnik-Schoneborn, H.H. Goebel, W. Schlote, S. Molaian, H. Omran, U. Ketelsen, R. Korinthenberg, D. Wenzel, H. Lauffer, M. Kreiss-Nachtsheim, et al. Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy Neurology, March 25, 2003; 60(6): 983 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sciacco, G. Fagiolari, C. Lamperti, S. Messina, P. Bazzi, L. Napoli, L. Chiveri, A. Prelle, G.P. Comi, N. Bresolin, et al. Lack of apoptosis in mitochondrial encephalomyopathies Neurology, April 24, 2001; 56(8): 1070 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mirabella, S. Di Giovanni, G. Silvestri, P. Tonali, and S. Servidei Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism Brain, January 1, 2000; 123(1): 93 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Duan, Y. Wang, M. Aviram, M. Swaroop, J. A. Loo, J. Bian, Y. Tian, T. Mueller, C. L. Bisgaier, and Y. Sun SAG, a Novel Zinc RING Finger Protein That Protects Cells from Apoptosis Induced by Redox Agents Mol. Cell. Biol., April 1, 1999; 19(4): 3145 - 3155. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koseki, N. Inohara, S. Chen, and G. Nunez ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases PNAS, April 28, 1998; 95(9): 5156 - 5160. [Abstract] [Full Text] [PDF] |
||||





